The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
Abstract
A new antibody platform combining anti-Psl and anti-PcrV activities provides enhanced protection and acts synergistically with antibiotics against Pseudomonas aeruginosa .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Vincent, J.-L. (1995) · JAMA · doi:10.1001/jama.1995.03530080055041 · Cited by 1,632
Single-Chain Antigen-Binding Proteins
Bird, R. E., Hardman, K. D., Jacobson, J. W., Johnson, S., Kaufman, B. M., Lee, S.-M., Lee, T., Pope, S. H., Riordan, G. S., & Whitlow, M. (1988) · Science · doi:10.1126/science.3140379 · Cited by 1,502
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Hauser, A. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2199 · Cited by 968
Goodman, A. L., Kulasekara, B., Rietsch, A., Boyd, D., Smith, R. S., & Lory, S. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.08.020 · Cited by 628
Role of polysaccharides in Pseudomonas aeruginosa biofilm development
Ryder, C., Byrd, M., & Wozniak, D. J. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.09.010 · Cited by 580
Tao, M. H., & Morrison, S. L. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2595 · Cited by 530
ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury
Finck‐Barbançon, V., Goranson, J., Zhu, L., Sawa, T., Wiener‐Kronish, J. P., Fleiszig, S. M. J., Wu, C., Mende‐Mueller, L., & Frank, D. W. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.4891851.x · Cited by 518
Hybrid hybridomas and their use in immunohistochemistry
Milstein, C., & Cuello, A. C. (1983) · Nature · doi:10.1038/305537a0 · Cited by 517
Feltman, H., Schulert, G., Khan, S., Jain, M., Peterson, L., & Hauser, A. R. (2001) · Microbiology · doi:10.1099/00221287-147-10-2659 · Cited by 446
Antibiotic interactions that select against resistance
Chait, R., Craney, A., & Kishony, R. (2007) · Nature · doi:10.1038/nature05685 · Cited by 439
Dual targeting strategies with bispecific antibodies
Kontermann, R. (2012) · mAbs · doi:10.4161/mabs.4.2.19000 · Cited by 435
Ventre, I., Goodman, A. L., Vallet-Gely, I., Vasseur, P., Soscia, C., Molin, S., Bleves, S., Lazdunski, A., Lory, S., & Filloux, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507407103 · Cited by 428
Jackson, K. D., Starkey, M., Kremer, S., Parsek, M. R., & Wozniak, D. J. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.14.4466-4475.2004 · Cited by 421
Ma, L., Jackson, K. D., Landry, R. M., Parsek, M. R., & Wozniak, D. J. (2006) · Journal of Bacteriology · doi:10.1128/jb.01202-06 · Cited by 399
The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU
Sato, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg290 · Cited by 390
Sawa, T., Yahr, T. L., Ohara, M., Kurahashi, K., Gropper, M. A., Wiener-Kronish, J. P., & Frank, D. W. (1999) · Nature Medicine · doi:10.1038/7391 · Cited by 362
Return to the Past: The Case for Antibody-Based Therapies in Infectious Diseases
Casadevall, A., & Scharff, M. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.1.150 · Cited by 318
Serum therapy revisited: animal models of infection and development of passive antibody therapy
Casadevall, A., & Scharff, M. D. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1695 · Cited by 251
Mishra, M., Byrd, M. S., Sergeant, S., Azad, A. K., Parsek, M. R., McPhail, L., Schlesinger, L. S., & Wozniak, D. J. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01704.x · Cited by 243
Key two‐component regulatory systems that control biofilm formation in Pseudomonas aeruginosa
Mikkelsen, H., Sivaneson, M., & Filloux, A. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02495.x · Cited by 242
Design and production of novel tetravalent bispecific antibodies
Coloma, M. J., & Morrison, S. L. (1997) · Nature Biotechnology · doi:10.1038/nbt0297-159 · Cited by 236
François, B., Luyt, C.-E., Dugard, A., Wolff, M., Diehl, J.-L., Jaber, S., Forel, J.-M., Garot, D., Kipnis, E., Mebazaa, A., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825334f6 · Cited by 181
DiGiandomenico, A., Warrener, P., Hamilton, M., Guillard, S., Ravn, P., Minter, R., Camara, M. M., Venkatraman, V., MacGill, R. S., Lin, J., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120033 · Cited by 174
Self-citationBodro, M., Sabé, N., Tubau, F., Lladó, L., Baliellas, C., Roca, J., Cruzado, J. M., & Carratalà, J. (2013) · Transplantation · doi:10.1097/tp.0b013e3182a049fd · Cited by 168
Pseudomonas aeruginosa Forms Biofilms in Acute Infection Independent of Cell-to-Cell Signaling
Schaber, J. A., Triffo, W. J., Suh, S. J., Oliver, J. W., Hastert, M. C., Griswold, J. A., Auer, M., Hamood, A. N., & Rumbaugh, K. P. (2007) · Infection and Immunity · doi:10.1128/iai.00586-07 · Cited by 164
Cross Talk between Type III Secretion and Flagellar Assembly Systems in Pseudomonas aeruginosa
Soscia, C., Hachani, A., Bernadac, A., Filloux, A., & Bleves, S. (2007) · Journal of Bacteriology · doi:10.1128/jb.01677-06 · Cited by 119
Warrener, P., Varkey, R., Bonnell, J. C., DiGiandomenico, A., Camara, M., Cook, K. E., Li, P., Zha, J., Chowdury, P., Sellman, B. R., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02643-14 · Cited by 119
Self-citation(2013) · Nature · doi:10.1038/495141a · Cited by 113
Tremblay, J. M., Mukherjee, J., Leysath, C. E., Debatis, M. E., Ofori, K., Baldwin, K., Boucher, C., Peters, R., Beamer, G., Sheoran, A. S., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01033-13 · Cited by 108
Yang, Z., Schmidt, D., Liu, W., Li, S., Shi, L., Sheng, J., Chen, K., Yu, H., Tremblay, J. M., Chen, X., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu196 · Cited by 107
Calculation of a new Meeh constant and experimental determination of burn size
Gilpin, D. A. (1996) · Burns · doi:10.1016/s0305-4179(96)00064-2 · Cited by 102
Dimasi, N., Gao, C., Fleming, R. L., Woods, R. M., Yao, X.-T., Shirinian, L., Kiener, P. A., & Wu, H. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.08.032 · Cited by 92
Self-citationPscF is a major component of the Pseudomonas aeruginosa type III secretion needle
Pastor, A., Chabert, J., Louwagie, M., Garin, J., & Attrée, I. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.09.028 · Cited by 87
Borkar, D. S., Fleiszig, S. M. J., Leong, C., et al. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.778 · Cited by 72
Machado, S. G., & Robinson, G. A. (1994) · Statistics in Medicine · doi:10.1002/sim.4780132202 · Cited by 64
Garey, K. W., Vo, Q. P., LaRocco, M., Gentry, L. O., & Tam, V. H. (2008) · Journal of Chemotherapy · doi:10.1179/joc.2008.20.6.714 · Cited by 47
Chen, W., Ying, T., & Dimitrov, D. S. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.761969 · Cited by 22
Cited by
Antibiotic resistance: a rundown of a global crisis
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,552
Bispecific antibodies: a mechanistic review of the pipeline
Labrijn, A. F., Janmaat, M. L., Reichert, J. M., & Parren, P. W. H. I. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0028-1 · Cited by 1,303
The making of bispecific antibodies
Brinkmann, U., & Kontermann, R. E. (2017) · mAbs · doi:10.1080/19420862.2016.1268307 · Cited by 923
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
Metadata
- Authors
- DiGiandomenico, A., Keller, A. E., Gao, C., Rainey, G. J., Warrener, P., Camara, M. M., Bonnell, J., Fleming, R., Bezabeh, B., Dimasi, N., Sellman, B. R., Hilliard, J., Guenther, C. M., Datta, V., Zhao, W., Gao, C., Yu, X.-Q., Suzich, J. A., & Stover, C. K.
- Venue
- Science Translational Medicine
- Published
- 2014-11-12
- Volume
- 6
- Issue
- 262
- Pages
- 262ra155-262ra155
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2103085550
- Cited by
- 277
- References
- 39
- FWCI
- 16.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.